Neovascular Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Neovascular Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 4D-150 for neovascular (wet) age-related macular degeneration is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]
Clinical trial update for Zifibancimig in participants with Neovascular Age-Related Macular Degeneration. The Phase 1/2 study is currently a…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial update assessing efficacy, safety, and durability of Faricimab in neovascular age-related macular degeneration; trial…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD) [Phase 3]
Phase 3 clinical trial evaluating the efficacy, safety, and pharmacokinetics of the Port Delivery System delivering ranibizumab in Chinese p…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD [Phase 3]
Phase 3 clinical trial comparing home OCT-guided treatment with the treat-and-extend approach for neovascular age-related macular degenerati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration [Phase 4]
A Phase 4 clinical trial update evaluating the efficacy of Faricimab in patients with neovascular age-related macular degeneration; the stud…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]
Phase 4 clinical trial evaluating different regimens of aflibercept 8 mg in Chinese patients with polypoidal choroidal vasculopathy, assessi…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD [Phase 2]
A Phase 2 study to evaluate the efficacy and safety of IBI302 in patients with neovascular age-related macular degeneration is currently rec…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1, Phase 2]
This clinical trial update indicates a Phase 1/2 study evaluating AR-14034 for Neovascular Age-Related Macular Degeneration is currently rec…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration [Phase 1]
A Phase 1 trial update reporting on the safety and tolerability assessment of PMC-403 in subjects with neovascular age-related macular degen…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting [NA]
This clinical trial update reports research identifying molecular signals in the vitreous humor associated with suboptimal response to VEGF …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]
A clinical trial update for a one-time investigational drug SAR402663 in adults with neovascular age-related macular degeneration; the study…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD) [Phase 3]
A Phase 3 clinical trial evaluating pharmacogenomics of anti-VEGF therapy in patients with neovascular (wet) age-related macular degeneratio…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO [Phase 2]
A Phase 2 dose-masked trial evaluating intravitreal Eye103 in participants with neovascular age-related macular degeneration or macular edem…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration [Phase 3]
A Phase 3 study evaluating efficacy and safety of Ixoberogene Soroparvovec (Ixo-vec) for neovascular age-related macular degeneration is cur…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration [Phase 4]
This document reports an ongoing Phase 4 trial of faricimab for neovascular age-related macular degeneration, focusing on quarterly maintena…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration [Phase 1]
A Phase 1 clinical trial evaluating ASKG712 for Neovascular Age-related Macular Degeneration is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Multicenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD [Phase 1, Phase 2]
A multicenter Phase 1/2 trial evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of SCT520FF in patients with n…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA] [Phase 2]
This clinical trial update discusses a Phase 2 study (LUNA) evaluating the safety and efficacy of ADVM-022 in treatment-experienced patients…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration
A clinical trial is evaluating faricimab injections for neovascular age-related macular degeneration, and the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1]
Phase 1 clinical trial evaluating the safety of BBC1501 given as an intravitreal injection in patients with neovascular age-related macular …
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD) [Phase 1]
Phase 1 clinical trial evaluating LX102 in patients with neovascular age-related macular degeneration; the study is currently not recruiting…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
This clinical trial update describes a long-term follow-up study of RGX-314 gene therapy delivered in the suprachoroidal space for neovascul…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of the intravitreal axitinib implant (OTX-TKI) for neovascular age-related macular…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Progression Suppression and Retinal Regression in VEGF-resistant AMD [NA]
This clinical trial update indicates ongoing recruitment for a study examining progression suppression and retinal regression in VEGF-resist…